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 ABSTRACT 
Mitochondrial dysfunction is a contributing factor to the advancement of various diseases 
including obesity, diabetes, and cardiovascular disease. Impairment in mitochondria brings about 
a diminished mitochondrial number and oxidative capacity. Leucine is known to stimulate 
muscle protein synthesis through transcription and translation of nuclear DNA leading to 
increases in mitochondrial biogenesis and fatty acid oxidation. However, the effects of leucine 
on anabolic factors of the mitochondrial genome, during catabolic conditions are not known. 
<bold> PURPOSE </bold> : To determine if leucine supplementation alters the negative 
effects of a high fat (60%) diet (HFD) on the mitochondrial genome by measuring the gene 
expression of mitochondrial protein synthesis markers TFAM, mtIF2, and TUFM, and 
mitochondrial biogenesis regulatory factors PGC-1α and COX-IV.  <bold> METHODS 
</bold : Male, Sprague-Dawley rats (n = 30 / dietary treatment) were fed either a control diet 
(C), control + leucine (CL), high-fat (HF), or high-fat + leucine (HFL) for 42 days. At the 
conclusion of 42 days, the soleus was extracted and used for analysis.  Quantitative PCR was 
conducted to determine gene expression for PGC-1α, TFAM, mtIF2, TUFM, and COX-IV. 
<bold> RESULTS </bold>:: mtIF2 gene expression increased 4-fold (p < 0.05) and TFAM 
gene expression increased 5-fold, with a control diet supplemented with leucine, respectively. 
mtIF2 gene expression increased 4-fold (p < 0.05) in response to a HFD compared to normal 
chow. However, TUFM gene expression declined (p < 0.05) in response to a HFD with or 
without leucine. <bold> CONCLUSION</bold>:: Leucine supplementation did not stimulate 
an increase in TFAM, mtIF2, and TUFM when exposed to a HFD, but does however stimulate 
an increase of mitochondrial protein synthesis markers in normal conditions. Indicating enhanced 
mitochondrial protein synthesis with leucine supplementation, at least under normal conditions.  
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      CHAPTER 1 
INTRODUCTION 
Obesity, the most common disorder in the United States and developing countries, is 
largely due to excess food intake and a lack of physical exercise (9). Major risk factors and 
comorbidities are associated with obesity including, diabetes, cardiovascular disease, 
musculoskeletal disorders, and carcinogenesis. With this increase in complications resulting from 
becoming obese, the individuals affected by this disease are experiencing a loss in high quality 
and productive life years. These illness states are regularly associated with an abnormal 
metabolism along with, lessened glucose uptake, modified protein turnover, and dysregulated 
lipid metabolism (21). 
 Increasing evidence suggests mitochondrial dysfunction to be a causative factor in many 
metabolic diseases including, obesity, diabetes, and cardiovascular disease (26, 35, 49, 52). 
These disruptions are often triggered by an increase flux of fatty acids (FAs), concomitant with 
the inability to switch carbohydrate fuel supplies, resulting from a high-fat diet (HFD). However, 
the underlying mechanisms of metabolic adaptation in response to HFD are only beginning to be 
unraveled, and the cause-and-effect relationship between HFD and mitochondrial dysfunction 
remain unclear. 
Mitochondria play a key role in whole body metabolic homeostasis by regulating several 
metabolic processes including, oxidative phosphorylation (OXPHOS), FA β-oxidation, reactive 
oxygen species (ROS), amino acid metabolism, and calcium homeostasis (37). Thus a change in 
metabolism, regarded as “mitochondrial dysfunction” has not been an uncommon result seen in 
the skeletal muscle of obese rodents (7, 53, 67) and humans (34, 62). One of the primary means 
	  2 
 
of increasing skeletal muscle oxidative capacity is through mitochondrial biogenesis (11). 
Mitochondrial biogenesis is the main process by which an increase in mitochondrial content and 
improvement of the functional capabilities of pre-existing mitochondria can be made (55).  
Interventions aimed to enhance mitochondrial biogenesis, and thereby mitochondrial 
functions have been reported to modulate insulin signaling and metabolic defects (59). Many 
strategies for preventing obesity have concentrated on dietary and lifestyle changes, for example, 
caloric restriction and becoming more active. These studies have revealed that despite the fact 
that weight loss can be achieved by modified dietary approaches, dieters find it difficult to 
maintain their weight loss over a certain time period  (33). A growing body of data has 
demonstrated a unique signaling role of the branched-chain amino acid (BCAA), leucine, on 
improving lipid and glucose metabolism (68). In these cells, leucine increased muscle protein 
synthesis via activation of the mammalian target of rapamycin signaling pathway (mTOR) (13), 
stimulated mitochondrial biogenesis (13), as well as fatty acid oxidation (45).  
Further data suggests that leucine stimulates SIRT-1, an activator of PGC-1α, which is 
associated with the initiation of mitochondrial biogenesis and fat oxidation in skeletal muscle 
cells (17). PGC-1α activates mitochondrial biogenesis and increases OXPHOS gene expression 
(21) by increasing the transcription, translation, and activation of transcription factors necessary 
for mitochondrial biogenesis. Among them, transcription factor of activated mitochondria 
(TFAM) is one of the regulatory factors needed for proper transcription of mitochondrial DNA 
(mtDNA) (49). In a 2007 study by Turner et al. (69), mitochondrial biogenesis and FA oxidative 
capacity was shown to be enhanced in skeletal muscle of mice on a HFD. 
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However, mitochondria are equipped with their own protein synthesis machinery, 
encompassing 13 protein-encoding genes that are all essential in the function of the electron 
transport system, and paramount to metabolic health. Two nuclear-encoded proteins, 
mitochondrial translation initiation factor 2 (mtIF2) and mitochondrial translation elongation 
factor-Tu (TUFM) have been identified as essential components of the mitochondrial translation 
process. mtIF2 and TUFM are translated in the cytosol by the canonical translation machinery, 
and imported to the mitochondria where they are primarily responsible for the translation 
initiation and elongation processes (47).   
Leucine supplementation has been well documented in stimulating certain protein 
synthesis related anabolic processes. However, the effect of leucine supplementation on the 
mitochondrion transcriptional and translational machinery in a catabolic situation, caused by 
HFD has yet to be established. The present study evaluates the impact of a HFD on markers of 
mitochondrial protein synthesis and mitochondrial biogenesis in rat soleus muscle. We further 
determined the effect of leucine supplementation on the anabolic factors involved in 
mitochondrial protein synthesis and mitochondrial biogenesis in the soleus muscle of rats 
submitted to a HFD.   
CHAPTER 2  
REVIEW OF LIERATURE 
This literature review is divided by topic into 5 main sections: 1) Obesity and the adverse 
effects on health status, 2) skeletal muscle and the functional changes in response to high-fat 
feeding, 3) mitochondrial regulation and its role in energy metabolism, 4) mitochondrial 
biogenesis as it relates to the regeneration of damaged mitochondria, and 5) the anabolic role of 
leucine in muscle protein synthesis and mitochondrial regulation. This review will include 
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general knowledge on high-fat feeding and how it has been shown to effect muscle protein 
synthesis in previous research, as well as how the mitochondrial dysfunction occurs in muscle 
under catabolic conditions. The two components of mitochondrial processes that will be 
examined in this study include protein synthesis and mitochondrial biogenesis.  Previous 
literature on markers of mitochondrial biogenesis and oxidative capacity, (PGC-1α and COX-IV) 
and the role these play in mitochondrial biogenesis within skeletal muscle will be reviewed.  
Markers of mitochondrial protein synthesis including TFAM, mtIF2, and TUFM, will be 
reviewed in their role in the transcriptional and translational processes. 
I. Obesity 
The rising epidemic of obesity is a leading health concern over the globe. The World 
Health Organization (WHO) characterizes obesity as a state of unusual fat mass gathered in 
adipose tissue, which may cause extreme health consequences (9). Obesity is the most frequently 
encountered metabolic disease across the world (9). In the United States, obesity is currently 
prevalent in more than two-thirds of the adult population, with rates anticipated to expand later 
on without mediation (54). Research has also shown that a key predictor of high blood pressure, 
type 2 diabetes, cardiovascular disease, and premature death are associated with obesity (29).  
Body mass index (BMI) is an indirect measure of obesity with a correlation to body fat 
mass in children, and adults (51). A BMI value greater than or equal to 30 kg/m2 is inferred to as 
being obese (75). Among adults, a greater proportion of men (41.2%) are overweight contrasted 
with women (28.4%), and women are more probable than men to be obese (75). The changes 
that have been brought by industrialization have negative impacts on both diet and physical 
activity levels which illustrates a piece of the expanding patterns in obesity over the previous 
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decade. Despite the poor health outcomes that arise due to excessive intake of energy-dense 
foods, the trend for obesity shows no sign of plateauing. Therefore, it is imperative to understand 
the physiological changes associated with the onset of obesity and determine an intervention that 
will prevent or attenuate impaired metabolic function.  
Complications and Comorbidities Associated with Obesity 
Complications of obesity in adults include dyslipidemia, type 2 diabetes, coronary illness, 
hypertension, disease, and premature death (74). Alongside the expansion in rate of obesity in 
adults, is complication of obesity infrequently seen in pediatric populace, for example: type 2 
diabetes, hypertension, cardiovascular ailment, and metabolic syndrome is getting more 
pervasive. Due to the expansion in complexities associated with obesity, those who are 
influenced by this ailment experience a decline in a high quality life when exposed to this 
sickness in early phases of life (69). It has likewise been recognized that when people are 
corpulent in their young lives, they encounter more trouble in losing this weight, so the 
overweight child usually turns into an overweight or obese adult. 
Obesity has also been shown to prompt insulin and leptin resistance, which brings about 
dysfunctional adipose and skeletal tissue (73). At the point when this happens, metabolic 
dysregulation occurs with hoisted levels of circulating free fatty acids (FFAs), and increased 
generation and discharge of pro-inflammatory adipokines. If left untreated, can prompt 
conditions such as liptoxicity, chronic inflammation, hypertension, atherosclerosis, and 
cardiovascular disease (68). As BMI increases, systolic and diastolic blood pressure additionally 
expand (63). An obese individual normally shows a debilitated lipid profile, where triglycerides 
are raised, HDL-cholesterol concentration is lessened, and low-density lipoprotein levels are 
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raised (63). It is likewise vital to note that visceral fat amassing is more risky for the 
advancement of cardiovascular ailment than fat on the extremities. Additionally, there is a link 
between obesity and advancement of type 2 diabetes with an increased risk of developing pre-
diabetic conditions as an aftereffect of impeded glucose tolerance, and insulin resistance in the 
tissues (69).  
The huge number of complications and comorbidities connected with obesity not only 
cause human suffering and diminished personal satisfaction in a few cases, but this also decides 
the surprising expenses connected with obesity. The assessed expenses of obesity extend from 
6% to 16% of aggregate medicinal services in the United States (54). This expense is likely 
going to climb with ease of access to unhealthy sustenance’s (54) and the decline of physical 
activity around occupants of the United States, as well as in developing nations. Due to the rising 
obesity epidemic and its connected comorbidities, it is critical to expand research addressing the 
issue.  
Etiology of Obesity 
There are many genes that are connected with energy metabolism, and there is now 
interest toward variables that have been illustrated to partake in the commitment of an 
individual’s vulnerability to put on weight and create comorbidities connected with obesity. The 
recent investigated supporters to the surge in obesity include diseases, lack of sleep, and a 
diminishment in an assortment of surrounding temperatures, mitochondrial dysfunction, aging, 
and assortative mating alongside epigenetics (16). This research focus has recently come of 
interest because of the now known effect of different supplements, and environmental 
compounds on the mitochondrial genome, which can prompt more serious disease processes.  
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II. Skeletal Muscle  
Structure and Function 
 Skeletal muscle is a standout amongst the most specialized structures in the whole body 
framework. There are in excess of 400 skeletal muscles, which constitute 40 percent to half of 
the total body mass, therefore making it the largest organ in the human body (73). Skeletal 
muscle cells (myofibers) are the fundamental unit of a singular skeletal muscle, and are 
comprised of many nuclei. Encompassing an individual nucleus is a district of cytoplasm known 
as the myonuclear domain (79). The nucleus assumes a critical part in the gene expression for its 
encompassing myonuclear area. 
Muscle fibers can adjust to quick or moderate twitch activity. This variation starts from a 
functional demand of the myofibers, and is fortified by incitement of fiber type-specific 
contractions (79). There are two principle contractile fiber types: glycolytic (type I) and 
oxidative (type II) fibers. Glycolytic muscles, for example, the gastrocnemius, are basically made 
out of fast twitch fibers and produce energy by means of anaerobic metabolic techniques. 
Oxidative muscles, such as soleus, are slower to contract yet oppose fatigue at a slower pace by 
means of oxidative metabolic methods (10). 
The peripheral region of the central nervous system (CNS) controls the skeletal muscles. 
In this manner, skeletal muscle is under cognizant or voluntary control. Voluntary movement is 
critical to the survival of humans, and is contributed to an endless show of proteins found in the 
mature skeletal muscle myofiber (79). Skeletal muscle is critical for exercises of day-by-day 
living, and obliges the facilitated regulation of inflammation, protein synthesis, and protein 
degradation for ideal muscle development (73). The three primary functions of the skeletal 
	  8 
 
muscle are force production of body movement and respiration, posture support, and body heat 
processing (73). 
Adenosine triphosphate (ATP) is a molecule that stores energy inferred from 
nourishments, and exchanges the energy to cells for biochemical processes (5). All muscles 
require ATP to produce contractions and movement. The capacity of the skeletal muscle cell is 
energized by glucose and lipid oxidation. Under ordinary augmenting conditions, glycolytic 
muscles use glucose, while oxidative muscles depend all the more on lipids (64). During physical 
activity, muscle cells are enacted and enhance their contractile performance. Conversely, 
muscles that do not undergo regular activity consider the opposing effect.  
Protein Synthesis  
Protein is an essential macromolecule, which helps make the structural component of 
cells, and is used within many biologic reactions (2). Proteins are composed of a vast array of 
smaller units called amino acids, connected in long chains. Twenty diverse amino acids are 
required in a particular order to characterize every protein’s shape and function. There are a 
multitude of specialized proteins that are involved in cellular activity including, insulin and 
muscle cell filaments. All things considered, proteins assume an essential part in the shaping of 
muscle tissue, and help support a healthy, and dynamic body. 
Protein synthesis is an event that occurs in all the cells of the body via transcription and 
translation processes. Messenger ribonucleic acid (mRNA) is synthesized in the nucleus where it 
receives the instructions from DNA (transcription) and transfers the code into the cytoplasm 
where protein synthesis occurs.  Ribosomal RNA (rRNA) specializes in the manufacture of 
ribosomes, the organelle that mRNA binds to in order to transfer the genetic code. Transfer RNA 
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(tRNA) resides in the cell cytoplasm, and is responsible for supplying the ribosomes with amino 
acids for protein synthesis (translation). After completion, the protein is removed from the 
ribosome and used as a structural component of a cell, or released to perform its proper function. 
A decline in skeletal muscle protein synthesis may have a negative impact on biological 
processes, and thus affect optimal health. 
III. Mitochondrial Regulation 
Mitochondrial Dysfunction in Health and Disease 
Within each cell are tiny sub-cellular organelles known as, mitochondria, that extract 
substantial amounts of energy from consumed nutrients, in order to fuel each individual cell and 
ultimately the whole human body (5). Mitochondria assume a crucial role in cellular metabolism, 
energy homeostasis, cell signaling, and apoptosis (25). Without mitochondria, the production of 
energy and all cellular functions would be compromised. Hence, maintaining abundant, 
functional mitochondria is essential to sustain life. 
An expansion of literature distinguishes mitochondrial dysfunction as a contributing factor to 
various pathophysiologies (25, 78). Given its significant role in the cell, it comes as no surprise 
that harm to mitochondria ultimately prompts disease (15). Case in point, mitochondrial 
dysfunction is perceived as a causative element in a wide assortment of disease states, which 
include obesity, diabetes, cardiovascular disease, cancer, and dementia (15, 78). The 
commonality amongst these disease pathophysiologies comes from the generation of ROS that 
bring about the accumulation of damage to mitochondrial DNA (mtDNA) (25). This eventually 
prompts mitochondrial dysfunction, resulting in more ROS; accordingly sustaining an endless 
loop (25). This mixture of oxidative stress and mitochondrial dysfunction is common to various 
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conditions; thus, the identification of factors that can attenuate oxidative stress and mitochondrial 
function is significant (22).  
Mitochondrial Structure and Function 
Mitochondria have a double membrane, bringing about different compartments inside the 
organelle. The semi-porous external mitochondrial membrane encases the organelle, 
differentiating it from the cytosol (27). The intermembrane space is located between the outer 
and inner membrane, and serves as an area for protein transport. Imbedded in the mitochondrial 
inner membrane are the enzymes responsible for extracting energy from food via ATP synthases 
and oxidative phosphorylation (OXPHOS) (32). The inner membrane is further 
compartmentalized to structure cristae, which builds the surface region in this way expanding the 
organelles capacity to synthesize ATP (32). Lastly, the mitochondrial matrix is the space within 
the mitochondrial membrane, and is the site of the citric acid cycle (also known as Krebs cycle) 
and also unsaturated fat oxidation (32).   
Fuel substrates such as, glucose, lipids, and fatty acids combine with oxygen to produce 
energy via OXPHOS and electron transport system (ETC), which is used to synthesize ATP. The 
ATP then spreads through the cell, and the required energy stored within the phosphate bonds of 
ATP is released to support cellular functions (15). The mitochondrial ETC consists of a series of 
redox reactions, where the substrates NADH and FADH2 donate electrons to a terminal election 
acceptor, oxygen. The outcome of electron transport is to build up a proton gradient outside the 
inner mitochondrial membrane. The resulting proton gradient navigates the inner mitochondrial 
membrane back to the matrix, thus activating the membrane ATP synthase and producing 80% 
of the cellular ATP.   
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OXPHOS involves an electrochemical gradient, whereby high-energy electrons of 
NADH are converted into ATP’s high-energy bonds. OXPHOS pathways do not require oxygen 
to produce ATP. The OXPHOS system consists of 5 multi-protein enzyme complexes (I-V) that 
all contribute in transporting electrons and proteins. The three protein pumps include complexes 
one, three, and four (42). Cytochrome c oxidase or complex IV (COX-IV) is an enzyme that 
catalyzes the final step in the electron transfer, and is considered a major regulation site for 
OXPHOS (42).  
While the primary responsibility of mitochondria is to produce ATP, this organelle is 
vital for various cell processes including cellular energy metabolism, cell signaling and apoptosis 
(25). As the primary site of citric acid cycle, lipolysis, and OXPHOS, mitochondria contain 
enzymes vital for the synthesis of lipids, cholesterol, heme, and assume a basic part in amino 
acid metabolism (25). Also, ROS are a product of mitochondria during OXPHOS. This 
controlled era of ROS by the mitochondria is vital for both cell signaling and apoptosis (25).  
Mitochondrial Protein Synthesis 
Each mitochondrion in a cell comprises its own genome (mtDNA), which is entirely 
separate from the DNA found in the nucleus (nuclear DNA). The mtDNA plays a key role in the 
expression of the respiratory chain. The components that make up the mitochondrial genome 
include, a large rRNA, small rRNA, proteins, and 22 tRNAs that are necessary for the translation 
of the RNA made by the mitochondria (32). Muscle mitochondrial content is a key factor of 
aerobic exercise capacity in healthy subjects.  
The mitochondrial genome codes for a very limited number of proteins, and rely on the 
nuclear DNA to provide the structural and enzymatic machinery required for protein synthesis. 
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There are more than 95% of proteins encoded in the nuclear DNA, synthesized in the cytoplasm, 
and transported to the mitochondria (21). Despite the limited amount of protein in the mtDNA, 
each protein is paramount in the expression of the respiratory chain, and thus mitochondrial 
health. The mitochondrial genome undergoes the same transcription and translation processes as 
nuclear DNA, but consists of different control proteins that are significant in the proper function 
of protein synthesis. Enzyme and transcription factors encoded in the nucleus direct the 
transcription of mtDNA. Transcription factors are regulatory proteins responsible for the 
expression of nuclear genes encoding respiratory chain proteins (21).  
The initiation of transcription begins at the heavy (PH) and light (PL) strand promoter sites 
of the DNA strand. The PH strand is responsible for coding most of the 13 genes that are encoded 
by the mtDNA, as well as, tRNA’s that are needed for proper translation into proteins (73). 
Transcription factors such as, mitochondrial transcription factor A (TFAM) are needed to ensure 
proper transcription of mtDNA, and of genes involved in the respiratory complexes (73). Both, 
PH and PL promoter sites, share an upstream enhancer that denotes the recognition site for 
TFAM. Transcription is then stimulated through specific binding to these recognition sites. 
TFAM also plays a role in stabilizing and maintaining the mitochondrial genome through 
nonspecific binding to random sites on mtDNA at a high affinity. Previous findings on TFAM 
knockout mouse concluded that, without TFAM embryonic cells were destructible, and there was 
a depletion of mtDNA content (71). Thereafter, it was suggested that TFAM levels correlate with 
increased levels of mtDNA in ragged-red muscle fibers (72). Ragged-red muscle fibers are 
associated with clumps of “diseased” mitochondria. Another study established a correlation 
between lower TFAM expression levels with decreased mtDNA levels in cells that contained 
depleted mtDNA (65).   
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The mitochondrial translation machinery relies on the nuclear genome that encodes 
protein necessary for proper translation. The protein components necessary for translation 
include, tRNA synthetases, mitochondrial ribosomal proteins, and initiation, elongation, and 
termination translation factors (2). The first qualification that must be met in order for translation 
to take place is, the mtDNA must be present, maintained, and transcribed (2). Secondly, proteins 
encoded in the nuclear genome that are responsible for proper mitochondria function have to be 
imported from the cell cytoplasm (2).  
Translation Factors 
A late report by Mercader et al. (47) implicates two key proteins for the mitochondrial 
translation process as novel applicant genes in human type 2 diabetes. These proteins are known 
as, mitochondrial translation initiation factor 2 (mtIF2) and mitochondrial translation elongation 
factor-Tu (TUFM). mtIF2 and TUFM display essential obligation regarding the translation 
initation and elongation processes (21). mtIF2 and TUFM are exceedingly monitored nuclear-
encoded proteins interpreted inside the cytosol by the standard translation machinery and 
imported to the mitochondria (21). There, they are fundamental components of the mitochondrial 
translation process inside the mitochondrial matrix (21). Right now, it is accepted that the start of 
interpretation happens upon mtIF2 binding to the mitoribosomal small subunit (SSU) which 
transports fMET-tRNA to the SSU at the aminoacyl acceptor site for interpretation (translation) 
of the mRNA, taking after edit TUFM is then comparably discharged from the unit through GTP 
hydrolysis permitting an alternate tRNA-TUFM to come in (21). This methodology proceeds to 
the end of the mRNA by means of a comparable stop codon mechanism to nuclear translation. 
Smits et al. (66) have beforehand distributed a more detailed audit of this procedure. The exact 
regulation of each one stage and protein included is still undetermined. In any case, it creates the 
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impression that various translation variables display potential binding sites to the mtIF2 and 
TUFM promoters, moreover Hornbeck et al. (28) noted 27 anticipated binding sites for 
posttranslational modification of TUFM. It thusly makes sense that complete mitochondrial 
biogenesis requires the upregulation of the mitochondrial translation machinery so as to include 
these key components. 
IV. Mitochondrial Biogenesis  
Mitochondrial functions are controlled, to a limited extent, by progressions in mitochondrial 
mass, such that diminished mitochondrial number contributes to a loss of function (68). Strict 
control over mitochondrial progress also allows this organelle to have changing reactions based 
upon adjustments in the environment such as, physical activity, availability of nutrients, and low 
temperature (68). This control is accomplished through mitochondrial biogenesis, which is a 
fundamental living methodology needed for development and advancement, in addition to meet 
the variable energy necessities of the cell (25). The synthesis, import, and integration of 
macromolecules to the mitochondrial reticulum is required in order for mitochondrial biogenesis 
to occur. Mitochondrial biogenesis is further convoluted by the presence of double genomes, and 
the fundamental replication of the mitochondrial genome (25). 
Mitochondria are produced from the transcription and translation of encoded genes in 
both the nuclear genome and mitochondrial genome. Correlation of mitochondria in numerous 
mouse tissues uncovered noteworthy congruity between protein levels and gene expression 
levels as measured by mRNA. This recommends that the tight control of mitochondrial 
biogenesis is to a great extent attained through transcriptional regulation (25). A gene is a 
specific region in the DNA, containing a message to produce various chemical substances. The 
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mitochondrial genome is a circular segment of DNA that comprises of 37 known genes (21, 25). 
Of those 37 genes encoded by mtDNA, 13 encode for enzymes involved in OXPHOS, 22 encode 
tRNA, and two encode mitochondrial rRNA (21).  
 Peroxisome proliferator activated receptor gamma co-activator alpha (PGC-1α) is often 
referred to as the “master regulator” of mitochondrial biogenesis (21), and is known to be the 
driving factor in forming oxidative type I fibers, and interrelate with many transcription factors 
(76). Increased expression of PGC-1α in myotubes strongly induces mitochondrial biogenesis by 
activating downstream biomarkers such as, nuclear respiratory factor 1 (NRF-1) and (NRF-2), 
which initiate expression of TFAM (76). The key role of PGC-1α in mitochondrial biogenesis 
has been obviously exhibited in transgenic studies (10, 41, 43). The overexpression of PGC-1α in 
skeletal muscle brings about increased mitochondrial abundance, gene expression, and enhanced 
physical performance (43). Interestingly, PGC-1α null mice showcase diminishes in 
mitochondrial gene expression and debilitated mitochondrial function (4, 41). Further evidence 
has shown PGC-1α to stimulate fatty acid oxidation, as well as improve insulin sensitivity in rats 
in a stressful environment (5).  
Impaired mitochondria and decreased mitochondrial density, and mtDNA content in 
high-fat diet-induced obesity are closely linked to the down regulation of PGC-1α and its 
downstream targets (60). Another study conducted on male rats reported that high-fat diet 
feeding induced skeletal muscle oxidative capacity by increasing PGC-1α, and the number of 
mitochondria in the cell (69). Moreover in the soleus muscle of high-fat diet-induced obese mice, 
COX IV levels, PGC-1α, NRF-1, and TFAM gene expression were decreased, as well as, oxygen 
consumption and ATP production (70). Taken together, these data indicate that PGC-1α directly 
relates external stimuli to the regulation of mitochondrial biogenesis and function. 
	  16 
 
While PGC-1α manages the expression of various mitochondrial genes, its own 
expression is directed by the energy needs of the cell (22). For instance, PGC-1α is 
communicated in a tissue-specific way, showing higher expression levels in tissues with higher 
energy requirements (22). Also, PGC-1α expression and activity is delicate to outer indicators of 
increased energy needs (22). For example, Greene et al. (21) observed an increased in PGC-1α 
expression following physical activity. Moreover, the action of PGC-1α is weakened by 
posttranslational adjustments of AMP-activated protein kinase (AMPK) and sirtuin1 (SIRT1), 
which are themselves, enacted by an expansion in cell energy needs (37, 56). This by and large 
infers that PGC-1α is a key impact in the long haul adjustment to the changing energy needs of 
the cell (25). 
Mitochondrial Biogenesis Assessment 
Mitochondria are exceptionally polymorphic, displaying structural variants that are 
dependent upon cell type, metabolic needs of the cell, and the cell cycle stage (25). 
Correspondingly, mitochondrial mass shifts around different organisms and tissue types, and is 
particularly needy upon the vitality necessities of the cell (25). One of the essential means by 
which mitochondrial capacity may be upgraded is through the biogenesis of new mitochondrial 
components (21). Miller et al. (48) suggested that the utilization of mitochondrial protein 
synthesis rates (mtFSR) may be the closest genuine measure of mitochondrial biogenesis, as 
these measures portray novel addition of protein components to the mitochondria in “real time". 
Given that control of mitochondrial biogenesis is accomplished through transcriptional 
regulation (25, 50), gene expression levels of key mitochondrial regulatory and component genes 
should be utilized to affirm changes in mitochondrial number instead of size (68). For instance, 
an upregulation in the expression of PGC-1α and/or NRF-1 are symbolic of expanded 
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mitochondrial biogenesis (68). The branched-chain amino (BCAA), leucine, essentially 
upregulates mitochondrial biogenesis as measured by gene expression levels in skeletal muscle 
cells (68). 
V. Leucine 
The inherent rise in obesity has sparked an interest in treatments and prevention methods that 
will reverse or attenuate mitochondrial dysfunction. Aligned with these strategies, BCCAs have 
shown to promote health and enhance physical performance (6). Leucine, isoleucine, and valine 
are defined as BCAAs, a gathering of essential amino acids that assume critical parts in protein 
synthesis and energy production (67).  
Of the BCAAs, leucine is the most broadly explored because of its differing physiological 
roles in mitochondrial function, protein synthesis, exercise recovery, glucose homeostasis, and 
insulin activity. In humans, BCAAs comprise between fifteen and twenty-five percent of total 
protein intake, and embody forty percent of the essential amino acids in body protein (2, 6). As 
essential amino acid, the BCAAs must be acquired through eating, and dairy items are one of the 
wealthiest wellsprings of BCAAs and of leucine specifically.  
Leucine and Protein Synthesis 
Both in vivo and in vitro studies have demonstrated leucine to have a unique signaling role in 
the cellular energy metabolism of normal skeletal muscle cells. Leucine is an activator of 
mammalian target of rapamycin (mTOR), a protein responsible for inducing muscle protein 
synthesis (5). Muscle protein synthesis is stimulated by leucine through mTOR-dependent and- 
independent mechanisms (12). Leucine is detected through mTOR, and plays a role in the 
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initiation of translation during protein synthesis. Leucine acts through mTOR independently by 
activating eIF4G (eukaryotic initiation factor-4G) thereby mediating protein synthesis in the 
muscle (13, 17). Under a dependent-mTOR mechanism, leucine associates eukaryotic initiation 
factor-4E (eIF4E) with S6 ribosomal protein to stimulate protein synthesis (17). Dietary 
supplementation with leucine has been shown to stimulate protein synthesis via insulin-
dependent mechanisms.  
Leucine has also been recognized as a key substrate in fatty acid oxidation and 
mitochondrial biogenesis in murine myotubes (67, 70). A previous study proposed leucine to 
regulate adipocyte lipid metabolism, and possibly serve to induce an increased flux of lipids to 
skeletal muscle, thereby providing the energy fuel to support leucine-stimulated protein synthesis 
(68). This “energy partitioning” effect was also seen in Zemel et al. (77), with leucine supporting 
fatty acid oxidation in adipocytes concomitant with activating mTOR and thus, increasing 
muscle protein synthesis. Furthermore, a 30% increase in mitochondrial mass in adipocytes, and 
50% in skeletal muscle cells was observed following leucine stimulation (77).  
Leucine and Mitochondrial Biogenesis 
Preceding information displays a mechanism, by which leucine is assisted, by its 
metabolite, β-hydroxy-β-methylbutyrate (HMB) to stimulate mitochondrial biogenesis 
independent of mTOR (2). The process begins with the metabolism of leucine into α-
ketoisocaproic acid (KIC) via an aminotransfer chemical reaction. Recent data demonstrate that 
leucine is dependent upon SIRT1, an activator of PGC-1α, to initiate mitochondrial biogenesis 
within these cells. Furthermore, leucine was shown to increase the gene expression of SIRT1, 
and mitochondrial component genes, including PGC-1α and NRF-1 (8). These genes provide 
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further verification that leucine signaling lead to an increase in mitochondrial number, rather 
than mass. 
The benefits of BCAA supplementation, leucine specifically, is known to promote 
mitochondrial wellbeing and possibly diminish oxidative stress (6). Supplementary data 
revealed, long-term administration of BCAA rich eating regimen brought about a noteworthy 
expand in the lifespan of male mice, supplemented by a simultaneous increase in mitochondrial 
biogenesis and lessened oxidative damage in skeletal and heart muscle (6).  
Given the evidence on the seemingly diverse effects of leucine, the interest in dietary 
leucine supplementation still remains prominent in research studies today. Such excitement is 
due to leucine appearing as a potent activator for protein synthesis, mitochondrial biogenesis, 
and lipid oxidation, which is a significant feature in understanding how skeletal muscle grows, 
and regulation of metabolic health. However, the extent of leucine supplementation on anabolic 
factors of the mitochondrial genome in skeletal muscle during HF feeding, to our knowledge has 
yet to be fully elucidated. Considering the involvement of leucine in modulating mitochondria 
abundance and function, determining the role of leucine in an obesenogenic environment can 
serve as a benefit for improving metabolic health, physical performance, and disease status. 
CHAPTER 3 
SPECIFIC AIMS 
Diet-induced obesity is caused by excessive intake of dietary fat over a period of time, 
and is associated with the development of type 2 diabetes and metabolic dysfunction (9). 
Mitochondria, the powerhouse of the cell, carries out cellular respiration by combining oxygen 
and fuel substrates such as, fats, carbohydrates, and proteins to be broken down into cellular 
energy in the form of adenosine triphosphate (ATP). The addition of new mitochondrial units, 
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and proteins is important to the ability to enhance total cell mitochondrial function. In obesity, 
there are a decreased number of mitochondria and oxidative capacity in skeletal muscle, thereby 
leading to dysfunction muscle metabolism.  
 The transcriptional co-activator peroxisome proliferator-activated receptor γ co-activator 
1 alpha (PGC-1 α) is commonly expressed in high oxidative tissues such as, the soleus muscle, 
and is known as the ‘master regulator’ of mitochondrial biogenesis (21). PGC-1α is responsible 
for binding to transcriptional factors that stimulate the activation of gene transcription and 
translation involved in mitochondrial biogenesis (21). Overexpressed levels of PGC-1α may 
negatively affect the activation of the downstream transcription genes, thus causing impaired 
mitochondrial protein synthesis in skeletal muscle.  
Anabolic factors that regulate mitochondrial biogenesis and fatty acid oxidation in 
muscle include, COX IV, TFAM, mtIF2, and TUFM. A study on lean and obese, insulin-
resistant Zucker rats showed an increase expression of mtIF2 following exercise, however obese 
animals were resistant to changes in TUFM, suggesting impaired elongation (21). Along these 
lines there is now preparatory confirmation showing atypical regulation of exercise-induced gene 
expression of mtIF2 and TUFM in diet-induced insulin resistance in mice. 
Leucine is an essential amino acid that has been shown to attenuate diet-induced obesity 
(37, 60), promote fatty acid oxidation (12), and improve mitochondrial biogenesis in skeletal 
muscle (61). Supplementation with leucine has been recognized as a key mediator during chronic 
inflammation by regulating glucose homeostasis and improving muscle protein synthesis (17). 
Prominent research has been done on leucine supplementation in HFD feeding; however, it is 
unknown how leucine affects biomarkers of the mitochondrial genome in response to a HFD. 
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Therefore, the central hypothesis of this proposal is: leucine supplementation induces an 
increased expression of mitochondrial biomarkers, thereby improving mitochondrial biogenesis 
and mitochondrial protein synthesis in skeletal muscle of HFD-fed rats.  
The purpose of this study was to determine the effect of leucine in HFD’s by targeting the 
biomarkers responsible for mitochondrial biogenesis and protein synthesis in the soleus muscle.  
Aim 1.  Determine the effect of leucine supplementation on markers of mitochondrial 
biogenesis in rats fed a high-fat diet. We hypothesize that a high fat diet supplemented with 
leucine will induce mitochondrial content and density via elevated PGC1-α and COX IV levels. 
Male, Sprague-Dawley rats were fed either a HFD (60% fat) or a control diet for 42 days in order 
to generate diet-induced obesity. Animals were randomized into treatment groups (n = 
30/group): 1) control/no leucine; 2) control/leucine; 3) high fat/ no leucine; 4) high fat/leucine. 
Body weight and food intake were measured daily. At the conclusion of 42 days, animals were 
sacrificed and the soleus tissue was isolated to measure the gene expression of biomarkers of 
mitochondrial biogenesis. RNA isolation and real time PCR were utilized to measure gene 
expression of PGC1-α and COX IV in the soleus tissue.  
Aim 2.  Determine the effect of leucine supplementation on biomarkers involved in 
mitochondrial protein synthesis in rats fed a high fat diet. We hypothesize that a high fat diet 
supplemented with leucine will induce transcription and translation activity via elevated TFAM, 
mtIF2, and TUFM levels. Experiments will examine the transcription factors that are co-
activated by PGC1-α including TFAM, mtIF2, and TUFM. This will allow investigators to 
determine the effect of HFD’s on muscle protein synthesis and where this effect occurs. We will 
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use RNA isolation and real time PCR to measure gene expression of TFAM, mtIF2, and TUFM 
in the soleus tissue. 
CHAPTER 4 
METHODS 
Animals and diets 
Eight-week-old male Sprague-Dawley rats (Harlan-Teklad), weighing 220 ± 2.0g at the 
beginning of the experiment, were singly housed in a secure, temperature and humidity-
controlled environment. Animals were kept on a 12:12 h reversed light-dark cycle (light 1900 – 
0700), and were fed commercial pelleted diet and water ad libitum for 9 days. Once the 
experiment began, rats were randomly assigned into treatment groups (n = 4-5/group): 1) control 
+ glycine; 2) control + leucine; 3) high fat + glycine; 4) high fat + leucine. Rats were fed 
macronutrient contents of 60% carbohydrate (CHO), 23.7% protein (PRO), 15.9% fat (control; 
Table 2) or 16.9% CHO, 23.4% PRO, 60% fat (HF; Table 2) containing 32 g of either glycine or 
leucine per kg of feed. A customized daily feeding schedule as previously reported Baum et al. 
(6), was used to mimic human eating behavior. Throughout the experimental period, rats had ad 
libitum access to water.  
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Table 1 
Diet composition    
 
Table 2 
Total kCal and percent energy  
Macronutrient Component Control Group High-Fat Group 
 
Kcal/Kg % Energy Kcal/Kg % Energy 
Carbohydrate (CHO) 2390 60 872 16.9 
Protein (PRO) 940 23.7 1204 23.4 
Fat 630 15.9 3060 60 
 
Body weights and food intake 
Body mass (BM) and food intake were monitored daily. Before feeding breakfast, rats 
were placed in a container on a scale and measurements were recorded in grams (g). Rats were 
given a set portion of either a chow diet (4g) or high-fat (3.1g).  
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Tissue collection 
After 42 days of feeding, rats were sacrificed and tissue was collected. Soleus muscles 
were removed and immediately frozen in liquid nitrogen. Samples were stored at -80°C for later 
analysis.  
RNA isolation, cDNA synthesis, and quantitative real time PCR 
Trizol reagent (Life technologies, Grand Island, NY, USA) was used to extract total RNA 
as suggested by the manufacturer. The extracted RNA was DNase treated, and the concentration 
and purity was determined spectrophotometrically using a (A260/A280) ratio of ≥1.6. cDNA was 
reverse transcribed from 1µg of total RNA using the Superscript Vilo cDNA synthesis kit (Life 
Technologies, Carlsbad, CA, USA) according to manufacturer instructions. Real Time 
Polymerase Chain Reaction (PCR) was carried out per manufacturer’s instruction using the 
StepOne Real-Time PCR System (Life Technologies, Applied Biosystems, Grand Island, NY), 
and results were analyzed using StepOne Software. Amplification of cDNA was performed in 
12.5 µL TaqMan Universal PCR Master Mix (Applied Biosystems), 1µL cDNA, 9µl RNase-free 
water, 1.25µL 18S primer (VIC), and 1.25 µL primer (FAM) (for appropriate target gene) in a 
final volume of 25 µL /well. Samples were incubated at 95°C for 4 min, followed by 40 cycles of 
denaturation, annealing and extension at 95°C, 55°C, and 72°C respectively. TaqMan 
fluorescence was measured at the end of the extension step each cycle. Fluorescence labeled 
probes for PGC-1α, TFAM, TUFM, mtIF2 (FAM dyes), and 18s (VIC dye) were purchased from 
Applied Biosystems and were quantified with TaqMan Universal mastermix. Fluorescence 
labeled probes for COX-IV was quantified with Cyber Green Universal mastermix. The ΔCt 
value [Ct (FAM) - Ct (VIC)] was calculated for each sample, using the 18s Ct as the endogenous 
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control. Final quantification of gene expression was calculated using the ΔΔCt method: Ct = [ΔCt 
(calibrator) – ΔCt (sample)]. Relative quantification was calculated as 2 –ΔΔCt. 
Statistical analysis  
The independent factors in this study were diet (C vs. HF), and treatment (leucine vs. no 
leucine). Dependent variables of interest included mRNA content of PGC-1α, TFAM, mtIF2, 
TUFM, and mitochondrial target protein COX-IV. A diet by treatment (2x2) ANOVA was used 
to analyze data regarding each dependent variable of interest. Statistical significance was set with 
an alpha value of p < 0.05. When significant F ratios were found, a two-tailed Student’s t test 
post hoc analysis was used to distinguish among means. All data were analyzed using 
commercial software (SAS, version 9.3, Cary, NC) and all results are reported as mean ± SEM. 
CHAPTER 5 
RESULTS 
Muscle Mass and Body Mass Data 
 Immediately following extraction the soleus was weighed and recorded. There was a 
decrease in the wet weight in both the normal and high-fat (HF) groups that were supplemented 
with leucine compared to their respective controls (Table 3). No significant difference was seen 
in the ratio of muscle mass to body weight with leucine supplementation in either group. 
Beginning approximately day 20, HF rats weighed significantly more than the normal rats 
(p<0.05) (Figure 1). The rats on a HFD gained significantly more weight (p < .0001) than those 
fed a normal diet with values of (409.07 ± 3.01 vs. 434.52 ± 3.01), respectively (Figure 1). 
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Figure 1. Body weights of rats fed normal diet (N) or HFD, supplemented with/without leucine 
for 42 days. Body weights were monitored daily. Values are means ± SEM, n=30. *p < 0.05.  
 
Table 3 
 
Muscle Mass, Body Mass, and Muscle to Body Mass Ratio   
 
 
Normal  High Fat 
  
 
No Leucine  
 
Leucine   
 
No Leucine 
 
Leucine 
Soleus   
(mg) 
 
166.3 ± 2.4 161.2 ± 3.1  180.2 ± 2.9 173.8 ± 2.8 
Body Mass  
(g) 
 
408.1 ± 3.5 410.1 ± 3.9  433.9 ± 4.7 435.2 ± 4.8 
Muscle Mass/Body 
Mass  
(mg/g) 
0.41 ± 0.01 0.39 ± 0.006   0.42 ± 0.004 0.40 ± 0.006 
Note. Data are means ± SEM. The HFD contained 60% fat.  
Gene Expression of Mitochondrial Transcription and Translation Factors 
A significant increase (p<0.05) in mtIF2 expression was observed in the CL group, with a 
4.0 fold increase compared to the control within the same group. Conversely, a blunted response 
in mtIF2 expression was observed in the HFL rats (Figure 2). Although a mean decrease was 
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seen in HFL, an interaction was demonstrated in the diets, with a significant increase (p = 0.018) 
in mtIF2 expression in the HF group compared to the normal group. 
 
Figure 2. Fold change comparison of mtIF2 expression in both normal and HF groups with or 
without leucine supplementation.  
*Shows significance within group, + Shows significance between groups 
 
Similarly, a 5.5 fold increase in TFAM expression was seen in rats on normal and leucine 
compared to their respective control (Figure 3). Although, without leucine supplementation, 
TFAM expression was approximately 3.5 fold greater in the HFD rats compared to the N rats.  
 
 
Figure 3. Fold change comparison of TFAM expression in both normal and HF groups with or 
without leucine supplementation. 
A main effect (p= 0.01) in the diet was seen in TUFM gene expression between the 
normal and HF groups. Within the normal group, regardless of the treatment, TUFM gene 
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expression was up regulated. However, a 1.0 fold decline in TUFM expression was demonstrated 
in the HF group. 
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Figure 4. Fold change comparison of TUFM expression in both normal and HF groups with or 
without leucine supplementation  
+ Shows significance between groups 
 
Effects of Leucine Supplementation on Mitochondrial Biogenesis Markers in Skeletal Muscle 
Markers involved in mitochondrial biogenesis including, PGC-1α and COX IV, were measured 
as to allow for quantification of the response to a HF diet. It was observed that in the CL group, 
PGC-1α gene expression was up regulated, however a trend decline (p=0.0724) was 
demonstrated in the HFL group (Figure 5). The HF group had a slight increase (0.5 fold increase) 
in PGC-1α expression compared to the normal group.  
COX-IV, a marker for mitochondrial volume, was unaffected by leucine supplementation in 
the HFD group (Figure 6). Although, no significance was found, COX-IV mRNA levels 
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increased 4.0-fold in the normal group supplemented with leucine compared to their respective 
controls.  
 
 
Figure 5. Fold change comparison of PGC-1α expression in both normal and HF groups with or 
without leucine supplementation.  
 
 
Figure 6. Fold change comparison of COX IV expression in both normal and HF groups with or 
without leucine supplementation. 
*Shows significance within group 
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CHAPTER 6 
 DISCUSSION 
It is presently perceived that nutrients can interrelate with transcription factors and 
contribute with biological processes. People respectably fluctuate in their individual reactions to 
diet regimens, and such approaches can help to look at the impact of nutrition on skeletal muscle 
function. The mitochondrion has long been involved in the pathogenesis of obesity and 
metabolic dysfunction (33, 36). Beforehand, it has been demonstrated that a mitochondrial 
insufficiency exists in obese people (30) and rodents (57). Nonetheless, the results of late studies 
recommend that there is a separation between mitochondrial dysfunction and the progression of 
obesity (3). Such a disconnection has led this study to focus on specific anabolic factors 
associated with the mitochondrial genome, which may contribute to the lack of mitochondrial 
efficiency. 
Under normal conditions, leucine seems to stimulate skeletal muscle mitochondrial 
biogenesis, as the increase of PGC-1α mRNA suggest. Leucine has been demonstrated to 
stimulate SIRT-1 activity, an activator of PGC-1α to start mitochondrial biogenesis and 
ultimately increase energy consumption within these cells. Previous data exhibit leucine's 
stimulation of mitochondrial biogenesis is independent of mTOR through leucine's metabolite, β-
hydroxy-β-methylbutyrate (HMB) (8). The breakdown of leucine is required to elicit the leucine-
induced stimulation on mitochondrial biogenesis. Thus, leucine is metabolized via a 
transamination reaction to α-ketoisocaproic acid (KIC). The two metabolites of KIC, isovaleryl-
CoA and HMB, along with leucine have been shown to significantly stimulate SIRT1 activity, 
while the branched-chain amino acid control valine did not (8). According to these analyses, an 
increment in mitochondrial number instead of mass is suggested to occur from leucine signaling.  
	  31 
 
A different sirtuin located in the mitochondria, SIRT3, was shown to modulate SIRT1-
dependent pathways. SIRT3 activation leads to stimulation of mitochondrial biogenesis and 
metabolism, resulting in enhanced fatty acid oxidation and a decrease in ROS production. Recent 
evidence on SIRT3 null mice have shown constitutive shortages in ATP production (1), and a 
propensity to develop the metabolic syndrome when exposed to a HFD (24). Such analyses 
reveal the importance of SIRT3, and indicate a possibility of leucine to modulate SIRT3 as well. 
It is notable, that PGC-1α gene expression appears to be already elevated in HF rats 
compared to the rats in the normal condition. Increased mRNA levels of PGC-1α, a master 
regulator of mitochondrial biogenesis (29), would involve the enhancement of skeletal muscle 
oxidative capacity. Review that fibers with a high oxidative capacity create ATP through 
oxidative phosphorylation in the mitochondrial inner membrane. It takes after that muscle cells, 
which hold more mitochondria, will have a higher oxidative capacity, and enhanced fatty acid 
oxidation. However, a disassociation between PGC-1α, enhancement in oxidative capacity (29), 
and fatty acid oxidation (27) has been accounted for in obese rodents.  
Recent evidence indicates that severely damaged or energetically dead mitochondria are 
cleared from the cell via autophagic degradation through a pathway known as mitophagy (23). 
The serine/threonine-protein kinase PINK1, accumulates specifically on the outer membrane of 
mitochondria (18), which then recruits Parkin and the downstream autophagy machinery that 
directs the defective organelles to lysosomes for degradation (39). The stresses that ultimately 
result in mitophagy could explain a potential mechanism of which there is an aggregation of 
“unhealthy” mitochondria associated with HF intake. Such an accumulation would essentially 
prompt a rise in the content of mitochondrial components, and subsequently be erroneously 
recognized as indication of mitochondrial biogenesis (29).  
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Considering the fact that the HFD rats were able to upregulate primary factors regulating 
mitochondrial biogenesis (PGC-1α) without a non-significant, leucine-induced enhancement of 
mitochondrial biogenesis (COX-IV), this study aimed to identify potential anabolic factors 
associated with the mitochondrial genome that may be unresponsive, or seen as rate-limiting in 
response to leucine supplementation. These data revealed that TFAM and mtIF2, regulators of 
mitochondrial transcription and translation initiation, respectively, were upregulated in rats fed a 
normal chow diet when supplemented with leucine. This discovery is novel in reporting that 
leucine instigates an increase in the expression of TFAM and mtIF2. Indicating enhanced 
capacity for transcription and translation of mitochondrial encoded genes in normal, healthy 
conditions. This data also suggests that leucine supplementation could lead to increased 
metabolic proteins derived from the mtDNA in mammals. Enhanced mitochondrial protein 
synthesis would likely prompt increased oxidative phosphorylation enzymes, for example, those 
utilized as a part of ETC, hence providing significant benefits in metabolic health.  
Indeed, collecting evidence demonstrates that HFDs are associated with an upregulation 
of most anabolic processes (23), and increased expression of key mitochondrial enzymes (14, 
20). This study revealed similar results showing that rats fed a HFD induced TFAM and mtIF2 
mRNA expression. However, TUFM mRNA, the primary factor in mitochondrial translation 
elongation was not enhanced in the HF group compared to the control group.  It has additionally 
been noted that mitochondrial translation factors are linked to insulin signaling through the 
NFкB1/IкBKB pathway (38). More specifically, TUFM cohorts with insulin signaling through 
the acknowledged translation pathway via ribosomal protein s6 (RPS6), eukaryotic translation 
initiation factor 4E (eIF4E), and eukaryotic translation elongation factor 2 (eEF2) (38).  
	  33 
 
It subsequently seems likely that such a disturbance in factors that regulate the canonical 
translation pathway due to exposure to a HFD, can have unfavorable consequences for TUFM. In 
addition, eIF4E-binding protein is a downstream effector of mTOR that repress translation by 
binding to mRNA, and has demonstrated sensitivity to diet-induced obesity (40). These data 
suggest the comparable mechanisms that oversee the expression of the canonical nuclear genome 
translation pathway, for example, mTOR may be included in the regulation of TUFM, however 
such an understanding obliges further examination to explain. Taken together these studies 
provide novel insight into a possible mechanism for mitochondrial dysfunction in skeletal muscle 
related to the translational response in a HF environment. 
 It is notable to mention, HFD’s attenuate the effect of leucine on mitochondrial protein 
synthesis, which could represent a disruption in the signaling process. The lack of leucine-
induced TUFM expression is proposed to be due to an impaired response of translation 
elongation in a HFD, in this way restricting the improvement of mitochondrial proteins. Taking 
into account recent studies, TUFM is the essential protein, which assumes a basic part in 
translation elongation, and along these lines the completion of mitochondrial translation (21). 
Despite the fact that this study did not specifically assess obese animals or protein content, 
Greene et al. (21) specified a “bottleneck” point when the obese animal has reached a maximum 
capacity of inducing mitochondrial translation elongation, and consequently neglect to prompt a 
measure of mitochondrial protein synthesis. Such a hypothesis is because of an increment in 
TUFM gene expression, however a diminished reduction in TUFM protein content following 
resistant exercise in obese, Zucker rats. 
Notably, a newly identified mitochondrial protein known as, AU- binding homolog of 
enoyl-coenzyme A (CoA) hydrates (AUH) demonstrates a bi-functional role in RNA-binding 
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activity and leucine catabolism (17). Furthermore, AUH is associated with fatty acid 
degradation, and has been demonstrated to have intrinsic hydratase enzymatic activity. 
Reduction or overexpression of the AUH protein is linked to defects in mitochondrial translation 
that prompt changes in mitochondrial morphology, diminish mitochondrial stability, biogenesis, 
and respiratory function. Regulation of leucine catabolism is paramount to monitor sufficient 
leucine levels for cytoplasmic protein synthesis and to provide anaplerotic substrates to the citric 
cycle located in the mitochondrial matrix (17). It therefore appears likely that mutations in the 
AUH protein inhibits leucine catabolism, and mitochondrial fatty acid oxidation resulting in a 
decline in mitochondrial protein synthesis during HFD conditions.    
In summary, excess energy intake can be directly associated with alterations in muscle 
mitochondrial activity. The rats fed a HFD showed signs of attempted mitochondrial biogenesis 
indicative of the enhanced expression of PGC-1α. However, Greene et al. (21) observed no 
enhancement in mitochondrial protein content, despite an induction in PGC-1α gene expression. 
Thus leading to the assumption that factors downstream of PGC-1α lead to impaired 
mitochondrial biogenesis in HF-induced rats. It appears that animals exposed to a HFD are able 
to integrate signals to initiate an adaptive oxidative response (TFAM, mtIF2), but the failed 
mitochondrial biogenesis may be due to an inadequate mitochondrial translation elongation 
(TUFM) response. Such an increase in mRNA expression may represent the mitochondrial 
components trying to compensate for the deleterious effects of HF intake.  
This study demonstrates that the BCAA leucine, has the potential to stimulate 
mitochondrial protein synthesis in skeletal muscles, at least under normal conditions. However, 
leucine loses its effect on mitochondrial transcription and translation processes during exposure 
to a HFD. This suggests that during HF feeding, dietary leucine elicits an incomplete response of 
	  35 
 
mitochondrial protein synthesis as the progression of HFD-induced obesity increases. This is 
important as it guides future research into the mechanisms behind this dysfunction.  On 
completion of this study it is need to be noted that protein content may be affected by high fat 
intake and so further studies on protein analysis is warranted. Also, the assessment of a small 
group number (n = 4/5) may have affected the outcome of significance, therefore a larger group 
analysis may be needed to detest greater significance on the anabolic factors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  36 
 
REFERENCES 
1. Ahn BH, Kim HS, Song S, Lee IH, Liu J, Vassilopoulos A, Deng CX and Finkel T. A role 
for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. 
Proc.Natl.Acad.Sci.U.S.A. 105: 38: 14447-14452, 2008.  
2. Anthony JC, Anthony TG, Kimball SR and Jefferson LS. Signaling pathways involved in 
translational control of protein synthesis in skeletal muscle by leucine. J.Nutr. 131: 3: 856S-
860S, 2001.  
3. Arany Z, Lebrasseur N, Morris C, Smith E, Yang W, Ma Y, Chin S and Spiegelman BM. 
The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in 
skeletal muscle. Cell.Metab. 5: 1: 35-46, 2007.  
4. Arany Z, Novikov M, Chin S, Ma Y, Rosenzweig A and Spiegelman BM. Transverse 
aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 
1alpha. Proc.Natl.Acad.Sci.U.S.A. 103: 26: 10086-10091, 2006.  
5. Baum JI, Layman DK, Freund GG, Rahn KA, Nakamura MT and Yudell BE. A reduced 
carbohydrate, increased protein diet stabilizes glycemic control and minimizes adipose tissue 
glucose disposal in rats. J.Nutr. 136: 7: 1855-1861, 2006.  
6. Blomstrand E and Saltin B. BCAA intake affects protein metabolism in muscle after but not 
during exercise in humans. Am.J.Physiol.Endocrinol.Metab. 281: 2: E365-74, 2001.  
7. Bonnard C, Durand A, Peyrol S, Chanseaume E, Chauvin MA, Morio B, Vidal H and 
Rieusset J. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of 
diet-induced insulin-resistant mice. J.Clin.Invest. 118: 2: 789-800, 2008.  
8. Bruckbauer A and Zemel MB. Effects of dairy consumption on SIRT1 and mitochondrial 
biogenesis in adipocytes and muscle cells. Nutr.Metab.(Lond) 8: 91-7075-8-91, 2011.  
9. Buettner R, Scholmerich J and Bollheimer LC. High-fat diets: modeling the metabolic 
disorders of human obesity in rodents. Obesity (Silver Spring) 15: 4: 798-808, 2007.  
10. Calvo JA, Daniels TG, Wang X, Paul A, Lin J, Spiegelman BM, Stevenson SC and 
Rangwala SM. Muscle-specific expression of PPARgamma coactivator-1alpha improves 
exercise performance and increases peak oxygen uptake. J.Appl.Physiol.(1985) 104: 5: 1304-
1312, 2008.  
11. Chanseaume E and Morio B. Potential mechanisms of muscle mitochondrial dysfunction in 
aging and obesity and cellular consequences. Int.J.Mol.Sci. 10: 1: 306-324, 2009.  
	  37 
 
12. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK and Puigserver P. 
mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional 
complex. Nature 450: 7170: 736-740, 2007.  
13. Dardevet D, Sornet C, Balage M and Grizard J. Stimulation of in vitro rat muscle protein 
synthesis by leucine decreases with age. J.Nutr. 130: 11: 2630-2635, 2000.  
14. Desler C, Hansen TL, Frederiksen JB, Marcker ML, Singh KK and Juel Rasmussen L. 
Is There a Link between Mitochondrial Reserve Respiratory Capacity and Aging? J.Aging Res. 
2012: 192503, 2012.  
15. Duchen MR. Roles of mitochondria in health and disease. Diabetes 53 Suppl 1: S96-102, 
2004.  
16. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama 
O, Makishima M, Matsuda M and Shimomura I. Increased oxidative stress in obesity and its 
impact on metabolic syndrome. J.Clin.Invest. 114: 12: 1752-1761, 2004.  
17. Garlick PJ. The role of leucine in the regulation of protein metabolism. J.Nutr. 135: 6 
Suppl: 1553S-6S, 2005.  
18. Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ and Springer 
W. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat.Cell 
Biol. 12: 2: 119-131, 2010.  
19. Ghibaudi L, Cook J, Farley C, van Heek M and Hwa JJ. Fat intake affects adiposity, 
comorbidity factors, and energy metabolism of sprague-dawley rats. Obes.Res. 10: 9: 956-963, 
2002.  
20. Golay A and Bobbioni E. The role of dietary fat in obesity. Int.J.Obes.Relat.Metab.Disord. 
21 Suppl 3: S2-11, 1997.  
21. Greene NP, Nilsson MI, Washington TA, Lee DE, Brown LA, Papineau AM, Shimkus 
KL, Greene ES, Crouse SF and Fluckey JD. Impaired exercise-induced mitochondrial 
biogenesis in the obese Zucker rat, despite PGC-1alpha induction, is due to compromised 
mitochondrial translation elongation. Am.J.Physiol.Endocrinol.Metab. 306: 5: E503-11, 2014.  
22. Handschin C and Spiegelman BM. Peroxisome proliferator-activated receptor gamma 
coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr.Rev. 27: 7: 728-735, 
2006.  
23. Hattori N, Saiki S and Imai Y. Regulation by mitophagy. Int.J.Biochem.Cell Biol. 2014.  
24. Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, 
Harris C, Biddinger S, Ilkayeva OR, Stevens RD, Li Y, Saha AK, Ruderman NB, Bain JR, 
	  38 
 
Newgard CB, Farese RV,Jr, Alt FW, Kahn CR and Verdin E. SIRT3 regulates mitochondrial 
fatty-acid oxidation by reversible enzyme deacetylation. Nature 464: 7285: 121-125, 2010.  
25. Hock MB and Kralli A. Transcriptional control of mitochondrial biogenesis and function. 
Annu.Rev.Physiol. 71: 177-203, 2009.  
26. Hofbauer KG. Molecular pathways to obesity. Int.J.Obes.Relat.Metab.Disord. 26 Suppl 2: 
S18-27, 2002.  
27. Holloway GP, Bonen A and Spriet LL. Regulation of skeletal muscle mitochondrial fatty 
acid metabolism in lean and obese individuals. Am.J.Clin.Nutr. 89: 1: 455S-62S, 2009.  
28. Hornbeck PV, Kornhauser JM, Tkachev S, Zhang B, Skrzypek E, Murray B, Latham 
V and Sullivan M. PhosphoSitePlus: a comprehensive resource for investigating the structure 
and function of experimentally determined post-translational modifications in man and mouse. 
Nucleic Acids Res. 40: Database issue: D261-70, 2012.  
29. Hotamisligil GS. Inflammation and metabolic disorders. Nature 444: 7121: 860-867, 2006.  
30. Iossa S, Lionetti L, Mollica MP, Crescenzo R, Botta M, Barletta A and Liverini G. 
Effect of high-fat feeding on metabolic efficiency and mitochondrial oxidative capacity in adult 
rats. Br.J.Nutr. 90: 5: 953-960, 2003.  
31. Jager S, Handschin C, St-Pierre J and Spiegelman BM. AMP-activated protein kinase 
(AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. 
Proc.Natl.Acad.Sci.U.S.A. 104: 29: 12017-12022, 2007.  
32. Jornayvaz FR and Shulman GI. Regulation of mitochondrial biogenesis. Essays Biochem. 
47: 69-84, 2010.  
33. Katz DL. Competing dietary claims for weight loss: finding the forest through truculent 
trees. Annu.Rev.Public Health 26: 61-88, 2005.  
34. Kelley DE, He J, Menshikova EV and Ritov VB. Dysfunction of mitochondria in human 
skeletal muscle in type 2 diabetes. Diabetes 51: 10: 2944-2950, 2002.  
35. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens 
R, Dyck JR, Newgard CB, Lopaschuk GD and Muoio DM. Mitochondrial overload and 
incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell.Metab. 7: 1: 
45-56, 2008.  
36. Kumar V, Atherton P, Smith K and Rennie MJ. Human muscle protein synthesis and 
breakdown during and after exercise. J.Appl.Physiol.(1985) 106: 6: 2026-2039, 2009.  
	  39 
 
37. La Vecchia C, Giordano SH, Hortobagyi GN and Chabner B. Overweight, obesity, 
diabetes, and risk of breast cancer: interlocking pieces of the puzzle. Oncologist 16: 6: 726-729, 
2011.  
38. Layman DK. The role of leucine in weight loss diets and glucose homeostasis. J.Nutr. 133: 
1: 261S-267S, 2003.  
39. Lazarou M, Jin SM, Kane LA and Youle RJ. Role of PINK1 binding to the TOM complex 
and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin. 
Dev.Cell. 22: 2: 320-333, 2012.  
40. Le Bacquer O, Petroulakis E, Paglialunga S, Poulin F, Richard D, Cianflone K and 
Sonenberg N. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 
4E-BP1 and 4E-BP2. J.Clin.Invest. 117: 2: 387-396, 2007.  
41. Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, 
Wozniak DF, Sambandam N, Bernal-Mizrachi C, Chen Z, Holloszy JO, Medeiros DM, 
Schmidt RE, Saffitz JE, Abel ED, Semenkovich CF and Kelly DP. PGC-1alpha deficiency 
causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight 
control and hepatic steatosis. PLoS Biol. 3: 4: e101, 2005.  
42. Li Y, Park JS, Deng JH and Bai Y. Cytochrome c oxidase subunit IV is essential for 
assembly and respiratory function of the enzyme complex. J.Bioenerg.Biomembr. 38: 5-6: 283-
291, 2006.  
43. Lin J, Handschin C and Spiegelman BM. Metabolic control through the PGC-1 family of 
transcription coactivators. Cell.Metab. 1: 6: 361-370, 2005.  
44. Lowell BB and Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 307: 
5708: 384-387, 2005.  
45. Macotela Y, Emanuelli B, Bang AM, Espinoza DO, Boucher J, Beebe K, Gall W and 
Kahn CR. Dietary leucine--an environmental modifier of insulin resistance acting on multiple 
levels of metabolism. PLoS One 6: 6: e21187, 2011.  
46. Matsuo T, Iwashita S, Komuro M and Suzuki M. Effects of high-fat diet intake on glucose 
uptake in central and peripheral tissues of non-obese rats. J.Nutr.Sci.Vitaminol.(Tokyo) 45: 5: 
667-673, 1999.  
47. Mercader JM, Puiggros M, Segre AV, Planet E, Sorianello E, Sebastian D, Rodriguez-
Cuenca S, Ribas V, Bonas-Guarch S, Draghici S, Yang C, Mora S, Vidal-Puig A, Dupuis J, 
DIAGRAM Consortium, Florez JC, MITIN Consortium, Zorzano A and Torrents D. 
Identification of novel type 2 diabetes candidate genes involved in the crosstalk between the 
mitochondrial and the insulin signaling systems. PLoS Genet. 8: 12: e1003046, 2012.  
	  40 
 
48. Miller BF and Hamilton KL. A perspective on the determination of mitochondrial 
biogenesis. Am.J.Physiol.Endocrinol.Metab. 302: 5: E496-9, 2012.  
49. Miller WC, Bryce GR and Conlee RK. Adaptations to a high-fat diet that increase exercise 
endurance in male rats. J.Appl.Physiol.Respir.Environ.Exerc.Physiol. 56: 1: 78-83, 1984.  
50. Mootha VK, Bunkenborg J, Olsen JV, Hjerrild M, Wisniewski JR, Stahl E, Bolouri 
MS, Ray HN, Sihag S, Kamal M, Patterson N, Lander ES and Mann M. Integrated analysis 
of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 115: 5: 
629-640, 2003.  
51. Must A and Anderson SE. Body mass index in children and adolescents: considerations for 
population-based applications. Int.J.Obes.(Lond) 30: 4: 590-594, 2006.  
52. Nemeth PM, Rosser BW, Choksi RM, Norris BJ and Baker KM. Metabolic response to a 
high-fat diet in neonatal and adult rat muscle. Am.J.Physiol. 262: 2 Pt 1: C282-6, 1992.  
53. Noland RC, Koves TR, Seiler SE, Lum H, Lust RM, Ilkayeva O, Stevens RD, Hegardt 
FG and Muoio DM. Carnitine insufficiency caused by aging and overnutrition compromises 
mitochondrial performance and metabolic control. J.Biol.Chem. 284: 34: 22840-22852, 2009.  
54. Ogden CL, Carroll MD, Kit BK and Flegal KM. Prevalence of childhood and adult 
obesity in the United States, 2011-2012. JAMA 311: 8: 806-814, 2014.  
55. Ostronoff LK, Izquierdo JM, Enriquez JA, Montoya J and Cuezva JM. Transient 
activation of mitochondrial translation regulates the expression of the mitochondrial genome 
during mammalian mitochondrial differentiation. Biochem.J. 316 ( Pt 1): Pt 1: 183-191, 1996.  
56. Poyton RO and McEwen JE. Crosstalk between nuclear and mitochondrial genomes. 
Annu.Rev.Biochem. 65: 563-607, 1996.  
57. Puigserver P, Wu Z, Park CW, Graves R, Wright M and Spiegelman BM. A cold-
inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92: 6: 829-839, 
1998.  
58. Rabinowitz D and Zierler KL. Forearm metabolism in obesity and its response to intra-
arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism. 
J.Clin.Invest. 41: 2173-2181, 1962.  
59. Ren J, Pulakat L, Whaley-Connell A and Sowers JR. Mitochondrial biogenesis in the 
metabolic syndrome and cardiovascular disease. J.Mol.Med.(Berl) 88: 10: 993-1001, 2010.  
60. Reznick RM, Zong H, Li J, Morino K, Moore IK, Yu HJ, Liu ZX, Dong J, Mustard KJ, 
Hawley SA, Befroy D, Pypaert M, Hardie DG, Young LH and Shulman GI. Aging-
associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. 
Cell.Metab. 5: 2: 151-156, 2007.  
	  41 
 
61. Riazi R, Wykes LJ, Ball RO and Pencharz PB. The total branched-chain amino acid 
requirement in young healthy adult men determined by indicator amino acid oxidation by use of 
L-[1-13C] phenylalanine. J.Nutr. 133: 5: 1383-1389, 2003.  
62. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH and Kelley DE. Deficiency 
of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54: 1: 8-14, 2005.  
63. Rohl M, Pasparakis M, Baudler S, Baumgartl J, Gautam D, Huth M, De Lorenzi R, 
Krone W, Rajewsky K and Bruning JC. Conditional disruption of IkappaB kinase 2 fails to 
prevent obesity-induced insulin resistance. J.Clin.Invest. 113: 3: 474-481, 2004.  
64. Samec S, Seydoux J, Russell AP, Montani JP and Dulloo AG. Skeletal muscle 
heterogeneity in fasting-induced upregulation of genes encoding UCP2, UCP3, PPARgamma 
and key enzymes of lipid oxidation. Pflugers Arch. 445: 1: 80-86, 2002.  
65. Seidel-Rogol BL and Shadel GS. Modulation of mitochondrial transcription in response to 
mtDNA depletion and repletion in HeLa cells. Nucleic Acids Res. 30: 9: 1929-1934, 2002.  
66. Smits P, Smeitink J and van den Heuvel L. Mitochondrial translation and beyond: 
processes implicated in combined oxidative phosphorylation deficiencies. J.Biomed.Biotechnol. 
2010: 737385, 2010.  
67. Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA and Smith SR. A high-
fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation 
in skeletal muscle. Diabetes 54: 7: 1926-1933, 2005.  
68. Sun X and Zemel MB. Leucine and calcium regulate fat metabolism and energy partitioning 
in murine adipocytes and muscle cells. Lipids 42: 4: 297-305, 2007.  
69. Turner N, Bruce CR, Beale SM, Hoehn KL, So T, Rolph MS and Cooney GJ. Excess 
lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence 
against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. 
Diabetes 56: 8: 2085-2092, 2007.  
70. Valerio A, Cardile A, Cozzi V, Bracale R, Tedesco L, Pisconti A, Palomba L, Cantoni 
O, Clementi E, Moncada S, Carruba MO and Nisoli E. TNF-alpha downregulates eNOS 
expression and mitochondrial biogenesis in fat and muscle of obese rodents. J.Clin.Invest. 116: 
10: 2791-2798, 2006.  
71. Vernochet C, Mourier A, Bezy O, Macotela Y, Boucher J, Rardin MJ, An D, Lee KY, 
Ilkayeva OR, Zingaretti CM, Emanuelli B, Smyth G, Cinti S, Newgard CB, Gibson BW, 
Larsson NG and Kahn CR. Adipose-specific deletion of TFAM increases mitochondrial 
oxidation and protects mice against obesity and insulin resistance. Cell.Metab. 16: 6: 765-776, 
2012.  
	  42 
 
72. Virbasius JV and Scarpulla RC. Activation of the human mitochondrial transcription factor 
A gene by nuclear respiratory factors: a potential regulatory link between nuclear and 
mitochondrial gene expression in organelle biogenesis. Proc.Natl.Acad.Sci.U.S.A. 91: 4: 1309-
1313, 1994.  
73. Waterlow JC. Whole-body protein turnover in humans--past, present, and future. 
Annu.Rev.Nutr. 15: 57-92, 1995.  
74. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL and Ferrante AW,Jr. 
Obesity is associated with macrophage accumulation in adipose tissue. J.Clin.Invest. 112: 12: 
1796-1808, 2003.  
75. Wredenberg A, Wibom R, Wilhelmsson H, Graff C, Wiener HH, Burden SJ, Oldfors A, 
Westerblad H and Larsson NG. Increased mitochondrial mass in mitochondrial myopathy 
mice. Proc.Natl.Acad.Sci.U.S.A. 99: 23: 15066-15071, 2002.  
76. Yan Z, Lira VA and Greene NP. Exercise training-induced regulation of mitochondrial 
quality. Exerc.Sport Sci.Rev. 40: 3: 159-164, 2012.  
77. Zemel MB. Proposed role of calcium and diary food components in weight management and 
metabolic health. Phys.Sportsmed 37: 2: 29-39, 2009.  
78. Zhang D, Mott JL, Farrar P, Ryerse JS, Chang SW, Stevens M, Denniger G and 
Zassenhaus HP. Mitochondrial DNA mutations activate the mitochondrial apoptotic pathway 
and cause dilated cardiomyopathy. Cardiovasc.Res. 57: 1: 147-157, 2003.  
79. Zhong H, Roy RR, Siengthai B and Edgerton VR. Effects of inactivity on fiber size and 
myonuclear number in rat soleus muscle. J.Appl.Physiol.(1985) 99: 4: 1494-1499, 2005.  
 
 
 
 
 
 
 
 
 
	  43 
 
 
APPENDIX 
 
 
	  44 
 
 
